Every

Every

Animal-free protein ingredients via precision fermentation

About Every

Simplify's Rating
Why Every is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Food & Agriculture

Industrial & Manufacturing

Biotechnology

Company Size

51-200

Company Stage

Series D

Total Funding

$308.8M

Headquarters

Daly City, California

Founded

2014

Overview

The EVERY Company creates animal-free protein, especially vegan egg protein, using precision fermentation to produce high-quality ingredients for food and beverage brands. Its products are not finished consumer foods but protein ingredients that manufacturers incorporate into vegan-friendly foods such as beverages and baked goods. The process works by using precision fermentation to grow microbial systems that produce specific proteins, which are then harvested and processed into usable ingredients. The company distinguishes itself through strategic B2B partnerships with large players like Ingredion and AB InBev BioBrew, enabling global distribution and scale, rather than competing as a consumer-brand producer. The goal is to supply scalable, sustainable, ethical protein ingredients to food brands, helping them meet rising demand for plant-based and animal-free options.

Simplify Jobs

Simplify's Take

What believers are saying

  • Grupo Palacios integrates EVERY Egg into Spanish omelets for 50-country distribution post-2026 EU approval.
  • Mario Patiño's CRO appointment drives $250M+ contracts across Latin America, EMEA, Asia-Pacific by 2027.
  • Healthier Comforts OvoPro powder sells out December 2025, unlocking direct consumer baking market.

What critics are saying

  • Precision BioSciences undercuts OvoPro pricing 40% via PBPRO, eroding B2B share within 12-24 months.
  • Sugar costs spike 50% from 2026 corn shortages, inflating COGS 25% against conventional eggs.
  • Formo Biotech captures 60% EU bakery share with approved egg lysozyme in 9-15 months.

What makes Every unique

  • Precision fermentation produces bioidentical OvoPro and OvoBoost egg proteins from Komagataella phaffii yeast.
  • FDA GRAS no-questions letters enable 'animal-free egg white protein' labeling without bioengineered status.
  • OvoBoost delivers neutral sensory profile for clear, protein-boosted beverages unlike egg alternatives.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$308.8M

Above

Industry Average

Funded Over

9 Rounds

Series D funding is typically for companies that are already well-established but need more funding to continue their growth. This round is often used to stabilize the company or prepare for an IPO.
Series D Funding Comparison
Below Average

Industry standards

$77M
$55M
Every
$70M
Twilio
$80M
Handshake
$100M
Affirm

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Unlimited Paid Time Off

Paid Holidays

Commuter Benefits

Wellness Program

Gym Membership

401(k) Company Match

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

2%

2 year growth

1%
Yahoo Finance
Mar 11th, 2026
Healthier Comforts launches first consumer animal-free egg white protein powder using EVERY's OvoPro™

The EVERY Company is supplying its precision-fermented egg white protein, OvoPro™, to Healthier Comforts for the first time, making the ingredient available to consumers. Healthier Comforts' Animal-Free Egg White Protein Powder launches on its website and Amazon in an 8oz resealable bag designed for home cooking and baking. Previously available only to food manufacturers in bulk, OvoPro™ addresses a gap in the vegan market for functional egg white replacements suitable for meringues, macarons and angel food cake. The product soft-launched in December 2025 and sold out quickly after gaining attention in vegan communities on Reddit. The partnership began when Healthier Comforts founder Aaron Vander Heyden met EVERY at IFT First in Chicago, recognising the potential to serve home cooks with a retail-ready format.

Business Wire
Nov 21st, 2025
EVERY Raises $55 Million in Fresh Capital Ahead of Nationwide Rollout

The EVERY Company, a biotechnology leader pioneering precision fermentation for highly functional proteins, today announced that it has successfully closed o...

IT Juzi
Nov 20th, 2025
The Every Company raises $55M Series D

The Every Company has raised $55 million in a Series D funding round.

Food Business Africa
Dec 3rd, 2024
The EVERY Company secures US$2M from US government for protein manufacturing study | Food Business Africa - Africa's No.1 Food & Beverage Manufacturing Industry Magazine and Website

USA - The EVERY Company, a biotechnology firm specializing in animal-free proteins, has received US$2 million in funding from the United States Department o ...

DigitalFoodLab
Jun 25th, 2024
12 notable deals and things to know this week (2024 - week #26)

Palacios, a Spanish agrifood leader, announced a partnership with The Every Co, a US-based startup using precision fermentation on egg proteins.

Recently Posted Jobs

Sign up to get curated job recommendations

Every is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →